Applications Published 20 June 2001

Published: 8-Mar-2002

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Plant fatty acid destaurase promoters
    Cargill Inc 1107661*

  • Manipulation of tocopherol levels in transgenic plants
    University of Nevada 1107662*

  • Electrically controlled transport of charged penetrants across barriers
    Idea 1107729*

  • Medicated chewing gum delivery system for nicotine
    JSR; Fuisz Technologies 1107730*

  • Synthetic tear fluid
    Stoffel, Wilhelm 1107731*

  • Oral liquid mucoadhesive compsns
    Procter & Gamble 1107732*

  • Omeprazole formulation
    Andrx Pharmaceuticals 1107735*

  • Microparticle compsn
    West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1107736*

  • Microparticles
    Quadrant Healthcare 1107737*

  • Novel pharmaceutical salt form
    Bristol-Myers Squibb 1107738*

  • Method for producing solid dosage forms
    Knoll 1107739*

  • Timed release tablet comprising naproxern and pseudoephedrine
    Platt, Chris 1107740*

  • Orally administered controlled drug delivery system providing temporal and spacial control
    Ranbaxy Laboratories 1107741*

  • Use of substance P antagonists for thr treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chroinic fatigue sydrome
    Novartis 1107744*

  • Use of 5HT-6 antagonists
    SmithKline Beecham 1107745*

  • Methods of using and compsns comprising dopamine reuptake inhibitors
    Sepracor 1107746*

  • Therapies for treating pulmonary diseases
    SithKline Beecham 1107747*

  • Methods and compsns employing optically pure S(+) vigabatrin
    Sepracor 1107748*

  • The use of fumaric acid derivatives in transplant medicine
    Fumapharm 1107749*

  • Pharmaceutical compsn with antitumour activity on the basis of carboplatin
    Pliva-Lachema 1107750*

  • Medicament containing platinum complex compounds and the use thereof
    Deutsches Krebsforschungszentrum Stiftung de oeffentlichen Rechts 1107751*

  • Pyrrolidine derivatives for vision and memory disorders
    GPI NIL Holdings 1107752*

  • Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-HT1 receptor
    Advanced Medicine 1107753*

  • Ureas and carbamates of N-heterocyclic carboxylic acids for vision and memory disorders
    GPI NIL Holdings 1107754*

  • N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders
    GPI NIL Holdings 1107755*

  • Novel isoxazolinone antibacterial agents
    Bristol-Myers Squibb 11077756*

  • Carbamate and urea compsns and neutrotrophic bases
    Guilford Pharmaceuticals 1107757*

  • Use of piperidines and/or piperzines as inhibitors of P38-alpha kinase
    Scios 1107758*

  • Pyridinones for the treatment of sexual dysfunction
    BASF 1107760*
  • You may also like